Nuveen
PRVA icon

Nuveen’s Privia Health PRVA Stock Holding History

Nuveen’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$37.7M Buy
1,465,145
+517,009
+55% +$12M 0.01% 874
2026
Q1 		$19.5M Sell
948,136
-152,901
-14% -$3.45M 0.01% 1155
2025
Q4 		$26.1M Sell
1,101,037
-91,281
-8% -$2.22M 0.01% 985
2025
Q3 		$29.7M Sell
1,192,318
-234,658
-16% -$5.05M 0.01% 898
2025
Q2 		$32.8M Buy
1,426,976
+228,813
+19% +$5.3M 0.01% 807
2025
Q1 		$26.9M Sell
1,198,163
-290,816
-20% -$6.76M 0.01% 940
2024
Q4 		$29.1M Buy
1,488,979
+246,393
+20% +$4.88M 0.01% 934
2024
Q3 		$22.6M Buy
1,242,586
+795,678
+178% +$15.2M 0.01% 1099
2024
Q2 		$7.77M Sell
446,908
-16,434
-4% -$291K ﹤0.01% 1728
2024
Q1 		$9.08M Buy
463,342
+1,772
+0.4% +$37.4K ﹤0.01% 1655
2023
Q4 		$10.6M Buy
461,570
+5,653
+1% +$127K ﹤0.01% 1552
2023
Q3 		$10.5M Sell
455,917
-170,138
-27% -$4.33M ﹤0.01% 1453
2023
Q2 		$16.3M Sell
626,055
-311,777
-33% -$8.23M 0.01% 1203
2023
Q1 		$25.9M Buy
937,832
+232,476
+33% +$6.14M 0.01% 879
2022
Q4 		$16M Buy
705,356
+139,822
+25% +$3.89M 0.01% 1186
2022
Q3 		$19.3M Buy
565,534
+202,626
+56% +$7.49M 0.01% 1038
2022
Q2 		$10.6M Buy
362,908
+58,253
+19% +$1.48M ﹤0.01% 1470
2022
Q1 		$7.23M Buy
304,655
+82,645
+37% +$1.95M ﹤0.01% 1845
2021
Q4 		$4.8M Sell
222,010
-13,348
-6% -$333K ﹤0.01% 2149
2021
Q3 		$6.07M Sell
235,358
-165,962
-41% -$5.79M ﹤0.01% 2104
2021
Q2 		$17.8M Buy
+401,320
New +$14.8M 0.01% 1465

Other funds holding PRVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Nuveen's PRVA Position: Q2 2026 in Review

Nuveen increased its Privia Health (PRVA) stake by 55% in Q2 2026, buying an estimated $12M and bringing the position to 1,465,145 shares worth $37.7M. The position accounts for 0.01% of the portfolio, ranked #874.

Nuveen first reported a position in PRVA in Q2 2021 and has held it in 21 quarters since. 301 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Nuveen held 1,465,145 shares of Privia Health worth $37.7M as of Q2 2026.
  • Nuveen bought 517,009 Privia Health shares in Q2 2026, an estimated $12M.
  • Privia Health made up 0.01% of Nuveen's portfolio in Q2 2026, its #874 holding.
  • Nuveen first reported a position in Privia Health in Q2 2021 and has held it in 21 quarters since.
  • 301 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.